HRCM
AGIO icon

Hood River Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Hood River Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-195,721
Closed -$10.8M – 148
2021
Q2 		$10.8M Sell
195,721
-2,102
-1% -$118K 0.32% 87
2021
Q1 		$10.2M Sell
197,823
-19,612
-9% -$971K 0.33% 90
2020
Q4 		$9.42M Buy
217,435
+3,535
+2% +$140K 0.31% 87
2020
Q3 		$7.49M Sell
213,900
-20,950
-9% -$918K 0.33% 85
2020
Q2 		$12.6M Buy
234,850
+112
+0% +$5.19K 0.56% 68
2020
Q1 		$8.33M Sell
234,738
-2,666
-1% -$123K 0.48% 72
2019
Q4 		$11.3M Buy
237,404
+17,341
+8% +$655K 0.49% 77
2019
Q3 		$7.13M Buy
220,063
+1,933
+0.9% +$80K 0.36% 83
2019
Q2 		$10.9M Buy
218,130
+7,754
+4% +$414K 0.51% 78
2019
Q1 		$14.2M Sell
210,376
-8,691
-4% -$506K 0.71% 60
2018
Q4 		$10.1M Buy
219,067
+75,488
+53% +$4.66M 0.6% 69
2018
Q3 		$11.1M Buy
143,579
+4,851
+3% +$390K 0.49% 79
2018
Q2 		$11.7M Buy
138,728
+5,406
+4% +$471K 0.6% 75
2018
Q1 		$10.9M Buy
133,322
+2,705
+2% +$209K 0.61% 75
2017
Q4 		$7.47M Buy
130,617
+9,227
+8% +$581K 0.43% 78
2017
Q3 		$8.1M Buy
121,390
+2,546
+2% +$153K 0.51% 74
2017
Q2 		$6.12M Buy
118,844
+2,626
+2% +$134K 0.42% 77
2017
Q1 		$6.79M Buy
116,218
+3,929
+3% +$188K 0.51% 79
2016
Q4 		$4.69M Buy
+112,289
New +$5.89M 0.41% 77

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Hood River Capital Management's AGIO Position: Q3 2021 in Review

Hood River Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 195,721 shares — an estimated $10.8M sold.

Hood River Capital Management first reported a position in AGIO in Q4 2016 and held it in 19 quarters. The position peaked at $14.2M in Q1 2019. 165 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Hood River Capital Management reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Hood River Capital Management sold 195,721 Agios Pharmaceuticals shares in Q3 2021, an estimated $10.8M.
  • Hood River Capital Management first reported a position in Agios Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Hood River Capital Management's Agios Pharmaceuticals position peaked at $14.2M in Q1 2019.
  • 165 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Hood River Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.